Idiopathic pulmonary fibrosis
2017 · The Lancet · 1,961 citations
https://doi.org/10.1016/s0140-6736(17)30866-8
M
Mark G. Jones
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
182
Papers
7.7K
Citations
32
h-index
69
i10-index
Mark G. Jones is an academic researcher from NIHR Southampton Biomedical Research Centre. The author has contributed to research in topics: Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis & Medical Imaging and Pathology Studies & Long-Term Effects of COVID-19. The author has an h-index of 32, co-authored 155 publications.
ORCID: 0000-0001-6308-6014Papers by this author
worksPhysical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study
2021 · The Lancet Respiratory Medicine · 642 citations
https://doi.org/10.1016/s2213-2600(21)00383-0
Idiopathic pulmonary fibrosis: Disease mechanisms and drug development
2020 · Pharmacology & Therapeutics · 612 citations
https://doi.org/10.1016/j.pharmthera.2020.107798
Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study
2022 · The Lancet Respiratory Medicine · 414 citations
https://doi.org/10.1016/s2213-2600(22)00127-8
Outcome of Hospitalization for COVID-19 in Patients with Interstitial Lung Disease. An International Multicenter Study
2020 · American Journal of Respiratory and Critical Care Medicine · 237 citations
https://doi.org/10.1164/rccm.202007-2794oc
Large-scale phenotyping of patients with long COVID post-hospitalization reveals mechanistic subtypes of disease
2024 · Nature Immunology · 86 citations
https://doi.org/10.1038/s41590-024-01778-0
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat